http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101355950-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dedd4d7ccb55cf2172c0ac4729772d24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate | 2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82c59eac74321ff73086080dec205579 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee5f7c59f1a2e4d15fb87dfa3c92daf0 |
| publicationDate | 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101355950-A |
| titleOfInvention | Rifamycin analogs and uses thereof |
| abstract | The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3'- hydroxy analogs, 5 '-halo and/or alkoxy analogs, and various 4 '-and/or 6'- substituents that incorporate a cyclic amine moiety. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110687218-A |
| priorityDate | 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 813.